This review aimed to summarize current evidence on the clinical usefulness of plaque characterization using contemporary ICI and the effects of high-intensity lipid-lowering therapies on vulnerable plaque features described in prospective studies and randomized clinical trials.
No takes yet. Share an insight, caveat, or question.
Biccirè et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: